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Abstract
Human chromosome 14q32.2 harbors the germline-derived primary DLK1-MEG3 intergenic differentially methylated region
(IG-DMR) and the postfertilization-derived secondary MEG3-DMR, together with multiple imprinted genes. Although
previous studies in cases with microdeletions and epimutations affecting both DMRs and paternal/maternal uniparental
disomy 14-like phenotypes argue for a critical regulatory function of the two DMRs for the 14q32.2 imprinted region, the
precise role of the individual DMR remains to be clarified. We studied an infant with upd(14)pat body and placental
phenotypes and a heterozygous microdeletion involving the IG-DMR alone (patient 1) and a neonate with upd(14)pat body,
but no placental phenotype and a heterozygous microdeletion involving the MEG3-DMR alone (patient 2). The results
generated from the analysis of these two patients imply that the IG-DMR and the MEG3-DMR function as imprinting control
centers in the placenta and the body, respectively, with a hierarchical interaction for the methylation pattern in the body
governed by the IG-DMR. To our knowledge, this is the first study demonstrating an essential long-range imprinting
regulatory function for the secondary DMR.
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Introduction
Human chromosome 14q32.2 carries a cluster of protein-coding
paternally expressed genes (PEGs) such as DLK1 and RTL1 and
non-coding maternally expressed genes (MEGs) such as MEG3
(alias, GTL2), RTL1as (RTL1 antisense), MEG8, snoRNAs, and
microRNAs [1,2]. Consistent with this, paternal uniparental disomy
14 (upd(14)pat) results in a unique phenotype characterized by
facial abnormality, small bell-shaped thorax, abdominal wall
defects, placentomegaly, and polyhydramnios [2,3], and maternal
uniparental disomy 14 (upd(14)mat) leads to less-characteristic but
clinically discernible features including growth failure [2,4].
The 14q32.2 imprinted region also harbors two differentially
methylated regions (DMRs), i.e., the germline-derived primary
DLK1-MEG3 intergenic DMR (IG-DMR) and the postfertilization-
derived secondary MEG3-DMR [1,2]. Both DMRs are hypermethy-
lated after paternal transmission and hypomethylated after maternal
transmission in the body, whereas in the placenta the IG-DMR alone
remains as a DMR and the MEG3-DMR is rather hypomethylated
[1,2]. Furthermore, previous studies in cases with upd(14)pat/mat-
like phenotypes have revealed that epimutations (hypermethylation)
and microdeletions affecting both DMRs of maternal origin cause
paternalization of the 14q32.2 imprinted region, and that epimuta-
tions (hypomethylation) affecting both DMRs of paternal origin cause
maternalization of the 14q32.2 imprinted region, while microdele-
tions involving the DMRs of paternal origin have no effect on the
imprinting status [2,5–8]. These findings, together with the notion
that parent-of-origin specific expression patterns of imprinted genes
are primarily dependent on the methylation status of the DMRs [9],
argue for a critical regulatory function of the two DMRs for the
14q32.2 imprinted region, with possible different effects between the
body and the placenta.
However, the precise role of individual DMR remains to be
clarified. Here, we report that the IG-DMR and the MEG3-DMR
show a hierarchical interaction for the methylation pattern in the
body, and function as imprinting control centers in the placenta
and the body, respectively. To our knowledge, this is the first study
demonstrating not only different roles between the primary and
secondary DMRs at a single imprinted region, but also an essential
regulatory function for the secondary DMR.
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Clinical reports
We studied an infant with upd(14)pat body and placental
phenotypes (patient 1) and a neonate with upd(14)pat body, but no
placental, phenotype (patient 2) (Figure 1). Detailed clinical
features of patients 1 and 2 are shown in Table 1. In brief,
patient 1 was delivered by a caesarean section at 33 weeks of
gestation due to progressive polyhydramnios despite amnioreduc-
tion at 28 and 30 weeks of gestation, whereas patient 2 was born at
28 weeks of gestation by a vaginal delivery due to progressive labor
without discernible polyhydramnios. Placentomegaly was observed
in patient 1 but not in patient 2. Patients 1 and 2 were found to
have characteristic face, small bell-shaped thorax with coat hanger
appearance of the ribs, and omphalocele. Patient 1 received
surgical treatment for omphalocele immediately after birth and
mechanical ventilation for several months. At present, she is 5.5
months of age, and still requires intensive care including oxygen
administration and tube feeding. Patient 2 died at four days of age
due to massive intracranial hemorrhage, while receiving intensive
care including mechanical ventilation. The mother of patient 1
had several non-specific clinical features such as short stature and
obesity. The father of patient 1 and the parents of patient 2 were
clinically normal.
Sample preparation
We isolated genomic DNA (gDNA) and transcripts (mRNAs,
snoRNAs, and microRNAs) from fresh leukocytes of patients 1 and
the parents of patients 1 and 2, from fresh skin fibroblasts of
patient 2, and from formalin-fixed and paraffin-embedded
placental samples of patient 1 and similarly treated pituitary and
adrenal samples of patient 2 (although multiple body tissues were
available in patient 2, useful gDNA and transcript samples were
not obtained from other tissues probably due to drastic post-
mortem degradation). We also made metaphase spreads from
leukocytes and skin fibroblasts. For comparison, we obtained
control samples from fresh normal adult leukocytes, neonatal skin
fibroblasts, and placenta at 38 weeks of gestation, and from fresh
leukocytes of upd(14)pat/mat patients and formalin-fixed and
paraffin-embedded placenta of a upd(14)pat patient [2,3].
Structural analysis of the imprinted region
We first examined the structure of the 14q32.2 imprinted region
(Figure 2). Upd(14) was excluded in patients 1 and 2 as well as in
the mother of patient 1 by microsatellite analysis (Table S1), and
FISH analysis for the two DMRs identified a familial heterozygous
deletion encompassing the IG-DMR alone in patient 1 and her
mother and a de novo heterozygous deletion encompassing the
MEG3-DMR alone in patient 2 (Figure 2). The microdeletions
were further localized by SNP genotyping for 70 loci (Table S1)
and quantitative real-time PCR (q-PCR) analysis for four regions
around the DMRs (Figure S1A), and serial direct sequencing for
the long PCR products harboring the deletion junctions
successfully identified the fusion points of the microdeletions in
patient 1 and her mother and in patient 2 (Figure 2). According to
the NT_026437 sequence data at the NCBI Database (Genome
Build 36.3) (http://preview.ncbi.nlm.nih.gov/guide/), the deletion
Figure 1. Clinical phenotypes of patients 1 and 2 at birth. Both
patients have bell shaped thorax with coat hanger appearance of the
ribs and omphalocele. In patient 1, histological examination of the
placenta shows proliferation of dilated and congested chorionic villi, as
has previously been observed in a case with upd(14)pat [2]. For
comparison, the histological finding of a gestational age matched (33
weeks) control placenta is shown in a dashed square. The horizontal
black bars indicate 100 mm.
doi:10.1371/journal.pgen.1000992.g001
Author Summary
Genomic imprinting is a process causing genes to be
expressed in a parent-of-origin specific manner—some
imprinted genes are expressed from maternally inherited
chromosomes and others from paternally inherited chro-
mosomes. Imprinted genes are often located in clusters
regulated by regions that are differentially methylated
according to their parental origin. The human chromo-
some 14q32.2 imprinted region harbors the germline-
derived primary DLK1-MEG3 intergenic differentially meth-
ylated region (IG-DMR) and the postfertilization-derived
secondary MEG3-DMR, together with multiple imprinted
genes. Perturbed dosage of these imprinted genes, for
example in patients with paternal and maternal uniparen-
tal disomy 14, causes distinct phenotypes. Here, through
analysis of patients with microdeletions recapitulating
some or all of the uniparental disomy 14 phenotypes, we
show that the IG-DMR acts as an upstream regulator for
the methylation pattern of the MEG3-DMR in the body but
not in the placenta. Importantly, in the body, the MEG3-
DMR functions as an imprinting control center. To our
knowledge, this is the first study demonstrating an
essential function for the secondary DMR in the regulation
of multiple imprinted genes. Thus, the results provide a
significant advance in the clarification of underlying
epigenetic features that can act to regulate imprinting.
Imprinting Control Centers at Human 14q32.2
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Patient 1 Patient 2 Upd(14)pat (n=20)
c
Present age 5.5 months Deceased at 4 days 0–9 years
Sex Female Female Male:Female=9:11
Karyotype 46,XX 46,XX
Pregnancy and delivery
Gestational age (weeks) 33 28 28–37
Delivery Caesarean Vaginal Vaginal:Caesarean=6:7
Polyhydramnios Yes No 20/20 (,28)
d
Amnioreduction (weeks) 26(28, 30) No 6/6
Placentomegaly Yes No 10/10
Growth pattern
Prenatal growth failure No No 1/13
Birth length (cm) 43 (WNR)
a 34 (WNR)
a
Birth weight (kg) 2.84 (.90 centile)
a 1.32 (WNR)
a
Postnatal growth failure Yes … 5/6
Present stature (cm) 56.3 (23.0 SD)
b …
Present weight (kg) 5.02 (23.0 SD)
b …
Characteristic face
Frontal bossing No Yes 5/7
Hairy forehead Yes Yes 9/10
Blepharophimosis Yes No 14/15
Depressed nasal bridge Yes Yes 13/13
Anteverted nares Yes No 6/10
Small ears Yes Yes 11/12
Protruding philtrum Yes No 15/15
Puckered lips No No 3/10
Micrognathia Yes Yes 11/12
Thoracic abnormality
Bell-shaped thorax Yes Yes 17/17
Mechanical ventilation Yes Yes 17/17
Abdominal wall defect
Diastasis recti … … 15/17
Omphalocele Yes Yes 2/17
e
Others
Short webbed neck Yes Yes 14/14
Cardiac disease No Yes (PDA) 5/10
Inguinal hernia No No 2/6
Coxa valga Yes No 3/4
Joint contractures Yes No 8/10
Kyphoscoliosis No No 4/7
Extra features Hydronephrosis
(bilateral)
WNR: within the normal range; SD: standard deviation; and PDA: patent ductus arteriosus.
a Assessed by the gestational age- and sex-matched Japanese reference data from the Ministry of Health, Labor, and Welfare (http://www.e-stat.go.jp/SG1/estat/
GL02020101.do).
b Assessed by the age- and sex-matched Japanese reference data..
c In the column summarizing the clinical features of 20 patients with upd(14)pat, the denominators indicate the number of cases examined for the presence or absence
of each feature, and the numerators represent the number of cases assessed to be positive for that feature; thus, the differences between the denominators and the
numerators denote the number of cases evaluated to be negative for that feature (adopted from reference [2]).
d Polyhydramnios has been identified by 28 weeks of gestation.
e Omphalocele is present in two cases with upd(14)pat and in two cases with epimutations [2].
doi:10.1371/journal.pgen.1000992.t001
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PLoS Genetics | www.plosgenetics.org 3 June 2010 | Volume 6 | Issue 6 | e1000992Figure 2. Physical map of the 14q32.2 imprinted region and the deleted segments in patient 1 and her mother and in patient 2
(shaded in gray). PEGs are shown in blue, MEGs in red, and the IG-DMR (CG4 and CG6) and the MEG3-DMR (CG7) in green. It remains to be clarified
whether DIO3 is a PEG, although mouse Dio3 is known to be preferentially but not exclusively expressed from a paternally derived chromosome [35].
For MEG3, the isoform 2 with nine exons (red bars) and eight introns (light red segment) is shown (Ensembl; http://www.ensembl.org/index.html).
Electrochromatograms represent the fusion point in patient 1 and her mother, and the fusion point accompanied by insertion of a 66 bp segment
(highlighted in blue) with a sequence identical to that within MEG3 intron 5 (the blue bar) in patient 2. Since PCR amplification with primers flanking
the 66 bp segment at MEG3 intron 5 has produced a 194 bp single band in patient 2 as well as in a control subject (shown in the box), this indicates
that the 66 bp segment at the fusion point is caused by a duplicated insertion rather than by a transfer from intron 5 to the fusion point (if the 66 bp
is transferred from the original position, a 128 bp band as well as a 194 bp band should be present in patient 2) (the marker size: 100, 200, and 300
bp). In the FISH images, the red signals (arrows) have been identified by the FISH-1 probe and the FISH-2 probe, and the light green signals
(arrowheads) by the RP11-566I2 probe for 14q12 used as an internal control. The faint signal detected by the FISH-2 probe in patient 2 is consistent
with the preservation of a ,1.2 kb region identified by the centromeric portion of the FISH-2 probe.
doi:10.1371/journal.pgen.1000992.g002
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PLoS Genetics | www.plosgenetics.org 4 June 2010 | Volume 6 | Issue 6 | e1000992Figure 3. Methylation analysis of the IG-DMR (CG4 and CG6) and the MEG3-DMR (CG7). Filled and open circles indicate methylated and
unmethylated cytosines at the CpG dinucleotides, respectively. (A) Structure of CG4, CG6, and CG7. Pat: paternally derived chromosome; and Mat:
Imprinting Control Centers at Human 14q32.2
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tion in patient 1 and her mother, and 4,303 bp (82,290,978–
82,295,280 bp) for the microdeletion in patient 2. The microdele-
tion in patient 2 also involved the 59 part of MEG3 and five of the
seven putative CTCF binding sites A–G [10], and was
accompanied by insertion of a 66 bp sequence duplicated from
MEG3 intron 5 (82,299,727–82,299,792 bp on NT_026437).
Direct sequencing of the exonic or transcribed regions detected no
mutation in DLK1, MEG3, and RTL1, although several cDNA
polymorphisms (cSNPs) were identified (Table S1). Oligoarray
comparative genomic hybridization identified no other discernible
structural abnormality (Figure S1B).
Methylation analysis of the two DMRs and the seven
putative CTCF binding sites
We next studied methylation patterns of the previously reported
IG-DMR (CG4 and CG6) and MEG3-DMR (CG7) (Figure 3A)
[2], using bisulfite treated gDNA samples. Bisulfite sequencing and
combined bisulfite restriction analysis using body samples revealed
a hypermethylated IG-DMR and MEG3-DMR in patient 1, a
hypomethylated IG-DMR and differentially methylated MEG3-
DMR in the mother of patient 1, and a differentially methylated
IG-DMR and hypermethylated MEG3-DMR in patient 2, and
bisulfite sequencing using placental samples showed a hyper-
methylated IG-DMR and rather hypomethylated MEG3-DMR in
patient 1 (Figure 3B).
We also examined methylation patterns of the seven putative
CTCF binding sites by bisulfite sequencing (Figure 4A). The sites
C and D alone exhibited DMRs in the body and were rather
hypomethylated in the placenta (Figure 4B), as observed in CG7.
Furthermore, to identify an informative SNP(s) pattern for allele-
specific bisulfite sequencing, we examined a 349 bp region
encompassing the site C and a 356 bp region encompassing the
site D as well as a 300 bp region spanning the previously reported
three SNPs near the site D, in 120 control subjects, the cases with
upd(14)pat/mat, and patients 1 and 2 and their parents.
Consequently, an informative polymorphism was identified for a
novel G/A SNP near the site D in only a single control subject,
and the parent-of-origin specific methylation pattern was con-
firmed (Figure 4C). No informative SNP was found in the
examined region around the site C, and no other informative SNP
was identified in the two examined regions around the site D, with
the previously known three SNPs being present in a homozygous
condition in all the subjects analyzed.
Expression analysis of the imprinted genes
Finally, we performed expression analyses, using standard
reverse transcriptase (RT)-PCR and/or q-PCR analysis for
multiple imprinted genes in this region (Figure 5A–5C). For
leukocytes, weak expression was detected for MEG3 and
SNORD114-29 in a control subject and the mother of patient 1
but not in patient 1. For skin fibroblasts, although all MEGs but no
PEGs were expressed in control subjects, neither MEGs nor PEGs
were expressed in patient 2. For placentas, although all imprinted
genes were expressed in control subjects, PEGs only were
expressed in patient 1. For the pituitary and adrenal of patient
2, DLK1 expression alone was identified.
Expression pattern analyses using informative cSNPs revealed
monoallelic MEG3 expression in the leukocytes of the mother of
patient 1 (Figure 5D), and biparental RTL1 expression in the
placenta of patient 1 (no informative cSNP was detected for DLK1)
and biparental DLK1 expression in the pituitary and adrenal of
patient 2 (RTL1 was not expressed in the pituitary and adrenal)
(Figure 5E), as well as maternal MEG3 expression in the control
leukocytes and paternal RTL1 expression in the control placentas
(Figure S2). Although we also attempted q-PCR analysis, precise
assessment was impossible for MEG3 in the mother of patient 1
because of faint expression level in leukocytes and for RTL1 in
patient 1 and DLK1 in patient 2 because of poor quality of mRNAs
obtained from formalin-fixed and paraffin-embedded tissues.
Discussion
The data of the present study are summarized in Figure 6.
Parental origin of the microdeletion positive chromosomes is based
on the methylation patterns of the preserved DMRs in patients 1
and 2 and the mother of patient 1 as well as maternal transmission
in patient 1. Loss of the hypomethylated IG-DMR of maternal
origin in patient 1 was associated with epimutation (hypermethy-
lation) of the MEG3-DMR in the body and caused paternalization
of the imprinted region and typical upd(14)pat body and placental
phenotypes, whereas loss of the hypomethylated MEG3-DMR of
maternal origin in patient 2 permitted normal methylation pattern
of the IG-DMR in the body and resulted in maternal to paternal
epigenotypic alteration and typical upd(14)pat body, but no
placental, phenotype. In this regard, while a 66 bp segment was
inserted in patient 2, this segment contains no known regulatory
sequence [11] or evolutionarily conserved element [12] (also
examined with a VISTA program, http://genome.lbl.gov/vista/
index.shtml). Similarly, while no control samples were available for
pituitary and adrenal, the previous study in human subjects has
shown paternal DLK1 expression in adrenal as well as monoallelic
DLK1 and MEG3 expressions in various tissues [11]. Furthermore,
the present and the previous studies [2] indicate that this region is
imprinted in the placenta as well as in the body. Thus, these
results, in conjunction with the finding that the IG-DMR remains
as a DMR and the MEG3-DMR exhibits a non-DMR in the
placenta [2], imply the following: (1) the IG-DMR functions
hierarchically as an upstream regulator for the methylation pattern
of the MEG3-DMR on the maternally inherited chromosome
in the body, but not in the placenta; (2) the hypomethylated
maternally derived chromosome. The PCR products for CG4 (311 bp) harbor 6 CpG dinucleotides and a G/A SNP (rs12437020), and are digested with
BstUI into three fragment (33 bp, 18 bp, and 260 bp) when the cytosines at the first and the second CpG dinucleotides and the fourth and the fifth
CpG dinucleotides (indicated with orange rectangles) are methylated. The PCR products for CG6 (428 bp) carry 19 CpG dinucleotides and a C/T SNP
(rs10133627), and are digested with TaqI into two fragment (189 bp and 239 bp) when the cytosine at the 9th CpG dinucleotide (indicated with an
orange rectangle) is methylated. The PCR products for CG7 harbor 7 CpG dinucleotides, and are digested with BstUI into two fragment (56 bp and
112 bp) when the cytosines at the fourth and the fifth CpG dinucleotides (indicated with orange rectangles) are methylated. These enzymes have
been utilized for combined bisulfite restriction analysis (COBRA). (B) Methylation analysis. Upper part shows bisulfite sequencing data. The SNP typing
data are also denoted for CG4 and CG6. The circles highlighted in orange correspond to those shown in Figure 3A. The relatively long CG6 was not
amplified from the formalin-fixed and paraffin-embedded placental samples, probably because of the degradation of genomic DNA. Note that CG4 is
differentially methylated in a control placenta and is massively hypermethylated in a upd(14)pat placenta, whereas CG7 is rather hypomethylated in a
upd(14)pat placenta as well as in a control placenta. Lower part shows COBRA data. U: unmethylated clone specific bands (311 bp for CG4, 428 bp for
CG6, and 168 bp for CG7); and M: methylated clone specific bands (260 bp for CG4, 239 bp and 189 bp for CG6, and 112 bp and 56 bp for CG7). The
results reproduce the bisulfite sequencing data, and delineate normal findings of the father of patient 1 and the parents of patient 2.
doi:10.1371/journal.pgen.1000992.g003
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both PEGs and MEGs in the body; and (3) in the placenta, the
hypomethylated IG-DMR directly controls the imprinting pattern
of both PEGs and MEGs. These notions also explain the
epigenotypic alteration in the previous cases with epimutations
or microdeletions affecting both DMRs (Figure S3).
It remains to be clarified how the IG-DMR and the MEG3-
DMR interact hierarchically in the body. However, the present
data, together with the previous findings in cases with epimuta-
tions [2,5–8], imply that MEG3-DMR can remain hypomethy-
lated only in the presence of a hypomethylated IG-DMR and is
methylated when the IG-DMR is deleted or methylated
irrespective of the parental origin. Furthermore, mouse studies
have suggested that the methylation pattern of the postfertiliza-
tion-derived Gtl2-DMR (the mouse homolog for the MEG3-DMR)
is dependent on that of the germline-derive IG-DMR [13]. Thus,
a preferential binding of some factor(s) to the unmethylated IG-
DMR may cause a conformational alteration of the genomic
structure, thereby protecting the methylation of the MEG3-DMR.
It also remains to be elucidated how the IG-DMR and the
MEG3-DMR regulate the expression of both PEGs and MEGs in
the placenta and the body, respectively. For the MEG3-DMR,
however, the CTCF binding sites C and D may play a pivotal role
in the imprinting regulation. The methylation analysis indicates
that the two sites reside within the MEG3-DMR, and it is known
that the CTCF protein with versatile functions preferentially binds
to unmethylated target sequences including the sites C and D
[10,14–16]. In this regard, all the MEGs in this imprinted region
can be transcribed together in the same orientation and show a
strikingly similar tissue expressions pattern [1,12], whereas PEGs
are transcribed in different directions and are co-expressed with
MEGs only in limited cell-types [1,17]. It is possible, therefore, that
preferential CTCF binding to the grossly unmethylated sites C and
D activates all the MEGs as a large transcription unit and represses
all the PEGs perhaps by influencing chromatin structure and
histone modification independently of the effects of expressed
MEGs. In support of this, CTCF protein acts as a transcrip-
tional activator for Gtl2 (the mouse homolog for MEG3) in the
mouse [18].
Such an imprinting control model has not been proposed
previously. It is different from the CTCF protein-mediated
insulator model indicated for the H19-DMR and from the non-
coding RNA-mediated model implicated for several imprinted
regions including the KvDMR1 [19]. However, the KvDMR1
harbors two putative CTCF binding sites that may mediate non-
coding RNA independent imprinting regulation [20], and the
imprinting control center for Prader-Willi syndrome [21] also
carries three CTCF binding sites (examined with a Search for
CTCF DNA Binding Sites program, http://www.essex.ac.uk/bs/
molonc/spa.html). Thus, while each imprinted region would be
regulated by a different mechanism, a CTCF protein may be
involved in the imprinting control of multiple regions, in various
manners.
This imprinted region has also been studied in the mouse.
Clinical and molecular findings in wildtype mice [1,22,23], mice
with PatDi(12) (paternal disomy for chromosome 12 harboring this
imprinted region) [13,24,25], and mice with targeted deletions for
the IG-DMR (DIG-DMR) [22,26] and for the Gtl2-DMR (DGtl2-
DMR) [27] are summarized in Table 2. These data, together with
human data, provide several informative findings. First, in both
the human and the mouse, the IG-DMR is differentially
methylated in both the body and the placenta, whereas the
MEG3/Gtl2-DMR is differentially methylated in the body and
exhibits non-DMR in the placenta. Second, the IG-DMR and the
MEG3/Gtl2-DMR show a hierarchical interaction on the
maternally derived chromosome in both the human and the
mouse bodies. Indeed, the MEG3/Gtl2-DMR is epimutated in
patient 1 and mice with maternally inherited DIG-DMR, and the
IG-DMR is normally methylated in patient 2 and mice with
maternally inherited DGtl2-DMR. Third, the function of the IG-
DMR is comparable between human and mouse bodies and
different between human and mouse placentas. Indeed, patient 1
has upd(14)pat body and placental phenotypes, whereas mice with
the DIG-DMR of maternal origin have PatDi(12)-compatible body
phenotype and apparently normal placental phenotype. It is likely
that imprinting regulation in the mouse placenta is contributed by
some mechanism(s) other than the methylation pattern of the IG-
DMR, such as chromatin conformation [22,28,29].
Unfortunately, however, the data of DGtl2-DMR mice appears
to be drastically complicated by the retained neomycin cassette in
the upstream region of Gtl2. Indeed, it has been shown that the
insertion of a lacZ gene or a neomycin gene in the similar upstream
region of Gtl2 causes severely dysregulated expression patterns and
abnormal phenotypes after both paternal and maternal transmis-
sions [30,31], and that deletion of the inserted neomycin gene
results in apparently normal expression patterns and phenotypes
after both paternal and maternal transmissions [31]. (In this
regard, although a possible influence of the inserted 66 bp segment
can not be excluded formally in patient 2, phenotype and
expression data in patient 2 are compatible with simple
paternalization of the imprinted region.) In addition, since the
apparently normal phenotype in mice homozygous for DGtl2-
DMR is reminiscent of that in sheep homozygous for the callipyge
mutation [32], a complicated mechanism(s) such as the polar
overdominance may be operating in the DGtl2-DMR mice [33].
Thus, it remains to be clarified whether the MEG3/Gtl2-DMR has
a similar or different function between the human and the mouse.
Two points should be made in reference to the present study.
First, the proposed functions of the two DMRs are based on the
results of single patients. This must be kept in mind, because there
might be a hidden patient-specific abnormality or event that might
explain the results. For example, the abnormal placental
phenotype in patient 1 might be caused by some co-incidental
aberration, and the apparently normal placenta in patient 2 might
be due to mosaicism with grossly preserved MEG3-DMR in the
placenta and grossly deleted MEG3-DMR in the body. Second,
Figure 4. Methylation analysis of the putative CTCF protein binding sites A–G. (A) Location and sequence of the putative CTCF binding
sites. In the left part, the sites C and D are painted in yellow and the remaining sites in purple. In the right part, the consensus CTCF binding motifs are
shown in red letters; the cytosine residues at the CpG dinucleotides within the CTCF binding motifs are highlighted in blue, and those outside the
CTCF binding motifs are highlighted in green [10]. (B) Methylation analysis. Upper part shows bisulfite sequencing data, using leukocyte genomic
DNA samples. Since PCR products for the site B contain a C/A SNP (rs11627993), genotyping data are also indicated. The circles highlighted in blue
correspond to those shown in Figure 4A. The sites C and D exhibit clear DMRs. Lower part indicates the results of the sites C and D using leukocyte
and/or placental genomic DNA samples. The findings are similar to those of CG7. (C) Allele-specific methylation pattern of the CTCF binding site D. A
novel G/A SNP has been identified in a single control subject, as shown on a reverse chromatogram delineating a C/T SNP pattern, while the
previously reported three SNPs were present in a homozygous condition. Methylated and unmethylated clones are associated with the ‘‘G’’ and the
‘‘A’’ alleles, respectively.
doi:10.1371/journal.pgen.1000992.g004
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and obesity are often observed in cases with upd(14)mat (Table
S2). However, the clinical features are non-specific and appear to
be irrelevant to the microdeletion involving the IG-DMR, because
loss of the paternally derived IG-DMR does not affect the
imprinted status [2,26]. Indeed, MEG3 in the mother of patient 1
showed normal monoallelic expression in the presence of the
differentially methylated MEG3-DMR. Nevertheless, since the
upd(14)mat phenotype is primarily ascribed to loss of functional
DLK1 (Figure S3B) [2,34], it might be possible that the
microdeletion involving the IG-DMR has affected a cis-acting
regulatory element for DLK1 expression (for details, see Note in the
legend for Table S2). Further studies in cases with similar
microdeletions will permit clarification of these two points.
In summary, the results show a hierarchical interaction and
distinct functional properties of the IG-DMR and the MEG3-
DMR in imprinting control. Thus, this study provides significant
advance in the clarification of mechanisms involved in the
imprinting regulation at the 14q32.2 imprinted region and the
development of upd(14) phenotype.
Figure 5. Expression analysis. (A) Reverse transcriptase (RT)-PCR analysis. L: leukocytes; SF: skin fibroblasts; and P: placenta. The relatively weak
GAPDH expression for the formalin-fixed and paraffin-embedded placenta of patient 1 indicates considerable mRNA degradation. Since a single exon
was amplified for DLK1 and RTL1, PCR was performed with and without RT for the placenta of patient 1, to exclude the possibility of false positive
results caused by genomic DNA contamination. (B) Quantitative real-time PCR (q-PCR) analysis of MEG3, MEG8, and miRNAs, using fresh skin
fibroblasts (SF) of patient 2 and four control neonates. Of the examined MEGs, miR433 and miR127 are encoded by RTL1as. (C) RT-PCR analysis for the
formalin-fixed and paraffin-embedded pituitary (Pit.) and the adrenal (Ad.) in patient 2. The bands for DLK1 are detected in the presence of RT and
undetected in the absence of RT, thereby excluding contamination of genomic DNA. (D) Monoallelic MEG3 expression in the leukocytes of the mother
of patient 1. The three cSNPs are present in a heterozygous status in gDNA and in a hemizygous status in cDNA. D: direct sequence. (E) Biparental
RTL1 expression in the placenta of patient 1 and biparental DLK1 expression in the pituitary and adrenal of patient 2. D: direct sequence; and S:
subcloned sequence. In patient 1, genotyping of RTL1 cSNP (rs6575805) using gDNA indicates maternal origin of the ‘‘C’’ allele and paternal origin of
the ‘‘T’’ allele, and sequencing analysis using cDNA confirms expression of maternally as well as paternally derived RTL1. Similarly, in patient 2,
genotyping of DLK1 cSNP (rs1802710) using gDNA denotes maternal origin of the ‘‘C’’ allele and paternal origin of the ‘‘T’’ alleles, and sequencing
analysis using cDNA confirms expression of maternally as well as paternally inherited DLK1.
doi:10.1371/journal.pgen.1000992.g005
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Ethics statement
This study was approved by the Institutional Review Board
Committees at National Center for Child health and Develop-
ment, University College Dublin, and Dokkyo University School
of Medicine, and performed after obtaining written informed
consent.
Primers
All the primers utilized in this study are summarized in
Table S3.
Sample preparation
For leukocytes and skin fibroblasts, genomic DNA (gDNA)
samples were extracted with FlexiGene DNA Kit (Qiagen), and
RNA samples were prepared with RNeasy Plus Mini (Qiagen) for
DLK1, MEG3, RTL1, MEG8 and snoRNAs, and with mirVana
miRNA Isolation Kit (Ambion) for microRNAs. For paraffin-
embedded tissues including the placenta, brain, lung, heart, liver,
spleen, kidney, bladder, and small intestine, gDNA and RNA
samples were extracted with RecoverAll Total Nucleic Acids
Isolation Kit (Ambion) using slices of 40 mm thick. For fresh
control placental samples, gDNA and RNA were extracted using
ISOGEN (Nippon Gene). After treating total RNA samples with
Figure 6. Schematic representation of the observed and predicted methylation and expression patterns. Deleted regions in patients 1
and 2 and the mother of patient 1 are indicated by stippled rectangles. P: paternally derived chromosome; and M: maternally derived chromosome.
Representative imprinted genes are shown; these genes are known to be imprinted in the body and the placenta [2] (see also Figure S2). Placental
samples have not been obtained in patient 2 and the mother of patient 1 (highlighted with light green backgrounds). Thick arrows for RTL1 in
patients 1 and 2 represent increased RTL1 expression that is ascribed to loss of functional microRNA-containing RTL1as as a repressor for RTL1 [26,36–
38]; this phenomenon has been indicated in placentas with upd(14)pat and in those with an epimutation and a microdeletion involving the two
DMRs (Figure S3A and S3C) [2]. MEG3 and RTL1as that are disrupted or predicted to have become silent on the maternally derived chromosome are
written in gray. Filled and open circles represent hypermethylated and hypomethylated DMRs, respectively; since the MEG3-DMR is rather
hypomethylated and regarded as non-DMR in the placenta [2] (see also Figure 3), it is painted in gray.
doi:10.1371/journal.pgen.1000992.g006
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were prepared with oligo(dT) primers from 1 mg of RNA using
Superscript III Reverse Transcriptase (Invitrogen), and those for
microRNAs were synthesized from 300 ng of RNA using TaqMan
MicroRNA Reverse Transcription Kit (Applied Biosystems). For
RTL1, cDNA samples were synthesized with RTL1-specific
primers that do not amplify RTL1as. Control gDNA and cDNA
samples were extracted from adult leukocytes and neonatal skin
fibroblasts purchased from Takara Bio Inc. Japan, and from a
fresh placenta of 38 weeks of gestation. Metaphase spreads were
prepared from leukocytes and skin fibroblasts using colcemide
(Invitrogen).
Structural analysis
Microsatellite analysis and SNP genotyping were performed as
described previously [2]. For FISH analysis, metaphase spreads
were hybridized with a 5,104 bp FISH-1 probe and a 5,182 bp
FISH-2 probe produced by long PCR, together with an RP11-
566I2 probe for 14q12 used as an internal control [2]. The FISH-1
and FISH-2 probes were labeled with digoxigenin and detected by
rhodamine anti-digoxigenin, and the RP11-566I2 probe was
labeled with biotin and detected by avidin conjugated to
fluorescein isothiocyanate. For quantitative real-time PCR anal-
ysis, the relative copy number to RNaseP (catalog No: 4316831,
Applied Biosystems) was determined by the Taqman real-time
PCR method using the probe-primer mix on an ABI PRISM 7000
(Applied Biosystems). To determine the breakpoints of microdele-
tions, sequence analysis was performed for long PCR products
harboring the fusion points, using serial forward primers on the
CEQ 8000 autosequencer (Beckman Coulter). Direct sequencing
was also performed on the CEQ 8000 autosequencer. Oligoarray
comparative genomic hybridization was performed with 16244K
Human Genome Array (catalog No: G4411B) (Agilent Technol-
ogies), according to the manufacturer’s protocol.
Methylation analysis
Methylation analysis was performed for gDNA treated with
bisulfite using the EZ DNA Methylation Kit (Zymo Research).
After PCR amplification using primer sets that hybridize both
methylated and unmethylated clones because of lack of CpG
Table 2. Clinical and molecular findings in wild-type and PatDi(12) mice and mice with maternally inherited DIG-DMR and DGtl2-
DMR.
Wildtype PatDi(12) DIG-DMR (,4.15 kb)
a DGtl2-DMR (,10 kb)
b
Neomycin cassette (+)
,Body.
Phenotype Normal Abnormal
c PatDi(12) phenotype
c Normal at birth
Lethal by 4 weeks
Methylation pattern
IG-DMR Differential Methylated Methylated
d Differential
Gtl2-DMR Differential Methylated Epimutated
e Methylated
d
Expression pattern
Pegs Monoallelic Increased (,2x) Biparental Grossly normal
Increased (2x or 4.5x)
f
Megs Monoallelic Absent Absent Decreased (,0.2,0.5x)
g
,Placenta.
Phenotype Normal Placentomegaly Apparently normal Not determined
Methylation pattern
IG-DMR Differential Methylated Not determined Not determined
Gtl2-DMR Non-DMR Non-DMR Not determined Not determined
Expression pattern
Pegs Monoallelic Not determined Increased (1.5,1.8x)
g Decreased (0.5,0.85x)
g
Megs Monoallelic Not determined Decreased (0.6,0.8x)
g Decreased (,0.1,1.0)
g
Remark Paternal transmission
h Paternal transmission
i
Biparental transmission
j
a The deletion size is smaller than that of patient 1 and her mother in this study, especially at the centromeric region.
b The microdeletion also involves Gtl2, and the deletion size is larger than that of patient 2 in this study.
c Body phenotype includes bell-shaped thorax with rib anomalies, distended abdomen, and short and broad neck.
d Hemizygosity for the methylated DMR of paternal origin.
e Hypermethylation of the maternally derived DMR.
f 2x Dlk1 and Dio3 expression levels and 4.5x Rtl1 expression level. The markedly elevated Rtl1 expression level is ascribed to a synergic effect between activation of the
usually silent Rtl1 of maternal origin and loss of functional microRNA-containing Rtl1as as a repressor for Rtl1 [26,36–38].
g The expression level is variable among examined tissues and examined genes.
h The DIG-DMR of paternal origin has permitted normal Gtl2-DMR methylation pattern, intact imprinting status, and normal phenotype in the body (no data on the
placenta).
i The DGtl2-DMR of paternal origin is accompanied by normal methylation pattern of the IG-DMR and variably reduced Pegs expression and increased Megs expression
in the body, and has yielded severe growth retardation accompanied by perinatal lethality.
j The homozygous mutants have survived and developed into fertile adults, despite rather altered expression patterns of the imprinted genes.
doi:10.1371/journal.pgen.1000992.t002
Imprinting Control Centers at Human 14q32.2
PLoS Genetics | www.plosgenetics.org 11 June 2010 | Volume 6 | Issue 6 | e1000992dinucleotides within the primer sequences, the PCR products were
digested with appropriate restriction enzymes for combined
bisulfite restriction analysis. For bisulfite sequencing, the PCR
products were subcloned with TOPO TA Cloning Kit (Invitrogen)
and subjected to direct sequencing on the CEQ 8000 auto-
sequencer.
Expression analysis
Standard RT-PCR was performed for DLK1, RTL1, MEG3,
MEG8, and snoRNAs using primers hybridizing to exonic or
transcribed sequences, and one ml of PCR reaction solutions was
loaded onto Gel-Dye Mix (Agilent). Taqman real-time PCR was
carried out using the probe-primer mixtures (assay No:
Hs00292028 for MEG3 and Hs00419701 for MEG8; assay ID:
001028 for miR433, 000452 for miR127, 000568 for miR379, and
000477 for miR154) on the ABI PRISM 7000. Data were
normalized against GAPDH (catalog No: 4326317E) for MEG3
and MEG8 and against RNU48 (assay ID: 0010006) for the
remaining miRs. The expression studies were performed three
times for each sample.
To examine the imprinting status of MEG3 in the leukocytes of
the mother of patient 1, direct sequence data for informative
cSNPs were compared between gDNA and cDNA. To analyze the
imprinting status of RTL1 in the placental sample of patient 1 and
that of DLK1 in the pituitary and adrenal samples of patient 2, RT-
PCR products containing exonic cSNPs informative for the
parental origin were subcloned with TOPO TA Cloning Kit,
and multiple clones were subjected to direct sequencing on the
CEQ 8000 autosequencer. Furthermore, MEG3 expression
pattern was examined using leukocyte gDNA and cDNA samples
from multiple normal subjects and leukocyte gDNA samples from
their mothers, and RTL1 expression pattern was analyzed using
gDNA and cDNA samples from multiple fresh normal placentas
and leukocyte gDNA from the mothers.
Supporting Information
Figure S1 Structural analysis. (A) Quantitative real-time PCR
analysis (q-PCR) for four regions (q-PCR-1-4) in patient 2. The q-
PCR-1 and q-PCR-2 regions are present in two copies whereas q-
PCR-3 and q-PCR-4 regions are present in a single copy in patient
2. The four regions are present in two copies in the parents and a
control subject, in a single copy in the two previously reported
patients with microdeletions involving the examined regions
(Deletion-1 and Deletion-2 are case 2 and case 3 in Kagami et
al. [2], respectively), and in three copies in a hitherto unreported
case with 46,XX,der(17)t(14;17)(q32.2;p13)pat who have three
copies of the 14q32.2 imprinted region. Since the microsatellite
locus D14S985 is present in two copies (Table S1) and the MEG3-
DMR is deleted (Figure 2) in patient 2, this has served to localize
the breakpoints. (B) Oligoarray comparative genomic hybridiza-
tion for a ,1 Mb imprinted region. All the signals remain within
the normal range (-1 SD , +1 SD) (shaded in light blue) in
patients 1 and 2.
Found at: doi:10.1371/journal.pgen.1000992.s001 (1.17 MB TIF)
Figure S2 Expression analysis. (A) Maternal MEG3 expression
in the leukocytes of normal subjects. Genotyping has been
performed for three cSNPs using genomic DNA (gDNA) and
cDNA of leukocytes from control subjects and gDNA samples of
their mothers, indicating that both maternally and non-maternally
(paternally) derived alleles are delineated in the gDNA, whereas
maternally inherited alleles alone are identified in cDNA. These
three cSNPs have also been studied in the mother of patient 1
(Figure 5D). (B) Paternal RTL1 expression in the placenta of a
normal subject. Genotyping has been carried out for RTL1 cSNP
using gDNA and cDNA samples of a fresh placenta and gDNA
sample from the mother, showing that both maternally and non-
maternally (paternally) derived alleles are delineated in the gDNA,
whereas a non-maternally (paternally) inherited allele alone is
detected in cDNA. This cSNP has also been examined in the
placenta of patient 1 (Figure 5E). Furthermore, the results confirm
that the primers utilized in this study have amplified RTL1, but not
RTL1as.
Found at: doi:10.1371/journal.pgen.1000992.s002 (0.39 MB TIF)
Figure S3 Schematic representation of the observed and
predicted methylation and expression patterns in previously
reported cases with upd(14)pat/mat-like phenotypes and in
normal and upd(14)pat/mat subjects. For the explanations of the
illustrations, see the legend for Figure 6. Previous studies have
indicated that (1) Epimutation-1, Deletion-1, Deletion-2, and
Deletion-3 lead to maternal to paternal epigenotypic alteration; (2)
Epimutation-2 results in paternal to maternal epigenotypic
alteration; and (3) Deletion-4 and Deletion-5 have no effect on
the epigenotypic status [2,5–8,26]. (A) Cases with typical or mild
upd(14)pat phenotype. Epimutation-1: Hypermethylation of the
IG-DMR and the MEG3-DMR of maternal origin in the body,
and that of the IG-DMR of maternal origin in the placenta (the
MEG3-DMR is rather hypomethylated in the placenta) (cases 6–8
in Kagami et al. [2]). Deletion-1: Microdeletion involving DLK1,
the two DMRs, and MEG3 on the maternally inherited
chromosome (case 2 in Kagami et al. [2]). Deletion-2: Microdele-
tion involving DLK1, the two DMRs, MEG3, RTL1, and RTL1as
on the maternally inherited chromosome (cases 3 and 5 in Kagami
et al. [2]). Deletion-3: Microdeletion involving the two DMRs,
MEG3, RTL1, and RTL1as on the maternally inherited chromo-
some (case 4 in Kagami et al. [2]). These findings are explained by
the following notions: (1) Epimutation (hypermethylation) of the
normally hypomethylated IG-DMR of maternal origin directly
results in paternalization of the imprinted region in the placenta
and indirectly leads to paternalization of the imprinted region in
the body via epimutation (hypermethylation) of the usually
hypomethylated MEG3-DMR of maternal origin. Thus, the
epimutation (hypermethylation) is predicted to have impaired
the IG-DMR as the primary target, followed by the epimutation
(hypermethylation) of the MEG3-DMR after fertilization; (2) Loss
of the hypomethylated MEG3-DMR of maternal origin leads to
paternalization of the imprinted region in the body; and (3) Loss of
the hypomethylated IG-DMR of maternal origin results in
paternalization of the imprinted region in the placenta. Further-
more, epigenotype-phenotype correlations imply that the severity
of upd(14)pat phenotype is primarily determined by the RTL1
expression dosage rather than the DLK1 expression dosage [2]. (B)
Cases with upd(14)mat-like phenotype. Epimutation-2: Hypo-
methylation of the IG-DMR and the MEG3-DMR of paternal
origin (Temple et al. [5], Buiting et al. [6], Hosoki et al. [7], and
Zechner et al. [8]). Deletion-4: Microdeletion involving DLK1, the
two DMRs, and MEG3 on the paternally inherited chromosome
(cases 9 and 10 in Kagami et al. [2]). Deletion-5: Microdeletion
involving DLK1, the two DMRs, MEG3, RTL1, and RTL1as on the
paternally inherited chromosome (case 11 in Kagami et al. [2] and
patient 3 in Buiting et al. [6]). These findings are consistent with
the following notions: (1) Epimutation (hypomethylation) of the
normally hypermethylated IG-DMR of paternal origin directly
results in maternalization of the imprinted region in the placenta
and indirectly leads to maternalization of the imprinted region in
the body through epimutation (hypomethylation) of the usually
hypermethylated MEG3-DMR of paternal origin. Thus, epimuta-
tion (hypomethylation) is predicted to have affected the IG-DMR
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tion) of the MEG3-DMR after fertilization; and (2) Loss of the
hypermethylated DMRs of paternal origin has no effect on the
imprinting status [2,26], so that upd(14)mat-like phenotype is
primarily ascribed to the additive effects of loss of functional DLK1
and RTL1 from the paternally derived chromosome (the effects of
loss of DIO3 appears to be minor, if any [2,35]). Although the
MEGs expression dosage is predicted to be normal in Deletion-4
and Deletion-5 and doubled in Epimutation-2 as well as in
upd(14)mat, it remains to be determined whether the difference in
the MEGs expression dosage has major clinical effects or not. (C)
Normal and upd(14)pat/mat subjects.
Found at: doi:10.1371/journal.pgen.1000992.s003 (2.72 MB TIF)
Table S1 The results of microsatellite and SNP analyses.
Found at: doi:10.1371/journal.pgen.1000992.s004 (0.19 MB
DOC)
Table S2 Clinical features in the mother of patient 1.
Found at: doi:10.1371/journal.pgen.1000992.s005 (0.09 MB
DOC)
Table S3 Primers utilized in the present study.
Found at: doi:10.1371/journal.pgen.1000992.s006 (0.14 MB
DOC)
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